Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure

Clinical Chemistry

Volumn 42, Issue 10, 1996, Pages 1627-1633

  Clerico, Aldo ^a   Iervasi, Giorgio ^a   Del Chicca, Maria Grazia ^a   Maffei, Silvia ^a   Berti, Sergio ^a   Sabatino, Laura ^a   Turchi, Stefano ^a   Cazzuola, Franco ^a   Manfredi, Cristina ^a   Biagini, Andrea ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

cardiac diseases; natriuretic peptides; sample handling

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOCHEMICAL MARKER; MONOCLONAL ANTIBODY I 125;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HORMONE DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE;

EID: 10244229129     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.10.1627     Document Type: Article

References (33)

1. De Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985;230:767-70.
2. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992;44:479-602.
3. Vesely DL. Atrial natriuretic hormones. Englewood Cliffs, NJ: Prentice Hall, 1992:1-53.
4. Espiner EA. Hormones of the cardiovascular system. In: DeGroot U. Endocrinology, 3rd ed. Philadelphia: WB Saunders, 1995: 2895-916.
5. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724-9.
6. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82:1730-6.
7. Clerico A, Iervasi G. Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides? J Card Failure 1995;1: 323-8.
8. Clerico A, Del Chicca MG, Giganti M, Zucchelli GC, Piffanelli A. Evaluation and comparison of the analytical performances of two RIA kits for the assay of atrial natriuretic peptides (ANP). J Nucl Med Allied Sci 1990;34:81-7.
9. Clerico A, Opocher G, Pelizzola D, Panzali AF. Andreone P, Del Chicca MG, et al. Evaluation of the analytical performance of RIA methods for measurement of atrial natriuretic peptides (ANP): a multicentre study. J Clin Immunoassay 1991;14:251-6.
10. Lewis HM, Ratcliffe WA, Stott RAW, Wilkins MR, Baylis PH. Development and validation of a two-site immunoradiometric assay for human atrial natriuretic factor in unextracted plasma. Clin Chem 1989;35:953-5.
11. Tattersal JE, Dawnay A, McLean C, Cattel WR. Immunoradiometric assay of atrial natriuretic peptide in unextracted plasma. Clin Chem 1990;36:885-9.
12. Clerico A, Del Chicca MG, Zucchelli GC, Materazzi F. Evaluation and comparison of four methods for plasma cortisol. J Nucl Biol Med 1976;20:119-25.
13. Clerico A, Iervasi G, Manfredi C, Salvadori S, Marastoni M, Turchi S, et al. Preparation of mono-radioiodinated tracers for studying the in vivo metabolism of atrial natriuretic peptide in humans. Eur J Nucl Med 1995;22:997-1004.
14. Iervasi G, Clerico A, Berti S, Pilo A, Vitek F, Biagini A, et al. ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake. Am J Physiol 1993;264: F480-9.
15. Clerico A, Iervasi G, Berti S, Pilo A, Vitek F, Salvadori S, et al. In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans. J Endocrinol Invest 1995;18:194-204.
16. Iervasi G, Clerico A, Pilo A, Berti S, Vitek F, Biagini A, et al. Kinetic study of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy: evidence for resistance to biological effects of the hormone even in patients with mild myocardial involvement. J Cardiovasc Pharmacol 1994;24:626-37.
17. Iervasi G, Clerico A, Berti S, Pilo A, Biagini A, Bianchi R, Donato L. Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling. Circulation 1995;91:2018-27.
18. Pilo A, Zucchelli GC, Malvano R, Masini S. Main features of computer algorithms for RIA data reduction. Comparison of some different approaches for the interpolation of dose-response curve. J Nucl Med All Sci 1982;26:235-48.
19. Schiffrin EL, St-Louis J, Essiambre R. Platelet binding sites and plasma concentration of atrial natriuretic peptide in patients with essential hypertension. J Hypertens 1988;6:565-72.
20. Duggan J, Kilfeather S, Lightman SL, O'Brien E, O'Malley K. Plasma atrial natriuretic peptide concentration and platelet atrial natriuretic peptide binding site density in ageing and hypertension. Clin Sci 1991;81:509-14.
21. Gutkowska J, Genest J, Thibault G, Garcia R, Larochelle P, Cusson JR, et al. Circulating forms and radioimmunoassay of atrial natriuretic factor. Endocrinol Metab Clin North Am 1987;16:183-98.
22. Yandle TG, Espiner EA, Nicholls MG, Duff H. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J Clin Endocrinol Metab 1986;63:72-9.
23. Kato J, Kida O, Kita T, Nakamura S, Sasaki A, Kodama K, Tanaka K. Free and bound forms of atrial natriuretic peptide (ANP) in rat plasma: preferential increase of free ANP in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP). Biochem Biophys Res Commun 1988;153:1084-9.
24. Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N, et al. Gamma-atrial natriuretic polypeptide (gamma-ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma-ANP fragment and alpha-ANP. J Clin Endocrinol Metab 1988;67:429-37.
25. Gutkowska J, Bourassa M, Roy D, Thibault G, Garcia R, Cantin M, Genest J. Immunoreactive atrial natriuretic factor (IR-ANF) in human plasma. Biochem Biophys Res Commun 1985;128: 1350-7.
26. Ohashi M, Fujio N, Nawata H, Kato KI, Ibayashi H, Kangawa K, Matsuo H. High plasma concentrations of human atrial natriuretic polypeptide in aged men. J Clin Endocrinol Metab 1987;64:81-5.
27. Richards AM, Tonolo G, McIntyre GD, Leckie BJ, Robertson IS. Radioimmunoassay for plasma alpha human atrial natriuretic peptide; a comparison of direct and preextracted methods. J Hypertens 1987;5:227-36.
28. Sugawara A, Nakao K, Morii N, Sakamoto M, Suda M, Shimokura M, et al. α-Human atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochem Biophys Res Commun 1985;129:439-46.
29. Rodeheffer RJ, Tanaka I, Imada T, Hollister AS, Robertson D, Inagami T. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. J Am Coll Cardiol 1986;8:18-26.
30. Schutten HJ, Henriken JH, Warberg J. Organ extraction of atrial natriuretic peptide (ANP) in man. Significance of sampling site. Clin Physiol 1987;7:125-32.
31. Hollister AS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami T. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest 1989;83:623-8.
32. Obata K, Yasue H, Okumura K, Matsuyama K, Ogawa H, Kurose M, et al. Atrial natriuretic polypeptide is removed by the lungs and released into the left atrium, as well as the right atrium, in humans. J Am Coll Cardiol 1990;15:1537-43.
33. Hensen J, Abraham WT, Lesnefsky EJ, Levenson B, Groves BM, Schroder K, et al. Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Kidney Int 1992;42:1333-9.